By David Mittleman

Doctors’ Concerns Grow Over Generic Drug Indian Imports

The other day I wrote about Ranbaxy, an Indian pharmaceutical company that has historically produced large quantities of generic drugs sent to the U.S. However, Ranbaxy and other Indian pharmaceutical companies are quickly withdrawing from the U.S. market as the FDA has ramped up its oversight of the imports for a variety of problems, including wrong dosage amounts and fabrication of drug effectiveness data. Now doctors are expressing concern over the remaining generic drugs manufactured in India, especially in the midst of a recent recall of generic Lipitor …read more